BreatheSuite

📍 St John’s, Canada🗓 Founded 2019👥 21 employees💰 Last funded Apr 2018
Medicare Advantage Plans & ACOs have seen their costs grow in COPD by 53% since 2010, because of high admission and readmission rates (22%). More expensive inhalers are not the only solution to curb this trend. Pulmonary Rehabilitation (PR) is a comprehensive intervention including endurance training, behaviour change and patient education which is proven to significantly improve COPD outcomes. Pulmonary Rehab has been around for decades and recommended by global and national guidelines, but less than 2% of COPD patients get access because there is one PR center for every 43,000 COPD patients in the US. BreatheSuite is a fully virtual Pulmonary Rehabilitation program designed to reduce COPD readmissions and medical expenses. BreatheSuite’s fully virtual program is built on clinically validated protocols, proven to save $5,700 per enrolled patient annually.
1
Total investors
1
Early stage
0
Mid stage
0
Late stage
2019
Founded
Investor geography1 country
United States
1
Frequently asked questions
Who invested in BreatheSuite?
BreatheSuite has 1 investors on record on gritt.io, including 1 early-stage backers.
When did BreatheSuite last raise funding?
The most recent investment in BreatheSuite recorded on gritt.io was in April 2018.
When was BreatheSuite founded?
BreatheSuite was founded in 2019.
What industry is BreatheSuite in?
BreatheSuite operates in Medical Equipment Manufacturing. Find similar Medical Equipment Manufacturing investors on gritt.io.
Where is BreatheSuite based?
BreatheSuite is headquartered in St John’s, Canada.